Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2021 Q2- Text added to 2021 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Antanasova, area, calcium, component, face, Faisal, harbored, immaterial, ISS, Li, low, Lui, molar, Monteverde, multikinase, nano, narazaciclib, null, oxidative, Piper, Port, requested, rigoserib, RSU, Sandler, schedule, spending, stable, tumorigenic, twelve
Removed:
AACR, clear, compliance, conduct, confidence, crucial, cytotoxicity, DC, defense, deleted, delivery, diagnosed, distancing, diversion, duration, evolve, geographic, globe, hospital, initiate, integrity, investigating, local, monitoring, monolactate, multi, nonclinical, noncompliance, outbreak, predicted, production, rapidly, receiving, redeem, regularly, renal, retained, review, serving, social, spread, travel, treat, ultimate, volume, Washington
Valuein 2021 Q2 filing- Value in 2021 Q3 filing
Original filings
Filing view